Evaluation of human major histocompatibility complex class I chain-related A as a potential target for tumor imaging

Bixia Tang, Zhi Yang, Jie Huang, Zhiyong Hao, Wenjing Li, Lianxian Cui, Wei He

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

To investigate the feasibility of using human major histocompatibility complex class I chain-related A (MICA) as a target for tumor imaging diagnosis, 10C6, a monoclonal antibody (mAb) that specifically recognizes MICA in vitro, was labeled with 99mTc (technetium) and administered into mice bearing MICA-positive human ovarian epithelial carcinoma line SKOV3. Measurement of organ-specific radioactivity showed that tumor accumulated radioactivity continuously, while the uptake in the other organs decreased over time. Scintigram showed that the tumor became clearly visible at 24 h post-injection of radio-labeled 10C6 mAb. These results suggest that MICA is a promising target for tumor imaging and mAb 10C6 may be used clinically for early tumor diagnosis.

Original languageEnglish
Pages (from-to)99-106
Number of pages8
JournalCancer Letters
Volume263
Issue number1
DOIs
Publication statusPublished - 8 May 2008
Externally publishedYes

Fingerprint

Major Histocompatibility Complex
Monoclonal Antibodies
Radioactivity
Neoplasms
Neoplasm Antibodies
Technetium
Radio
Early Diagnosis
Carcinoma
Injections

Keywords

  • Antibody
  • Diagnosis
  • Imaging
  • MICA
  • Ovarian epithelial carcinoma
  • Technetium

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology

Cite this

Evaluation of human major histocompatibility complex class I chain-related A as a potential target for tumor imaging. / Tang, Bixia; Yang, Zhi; Huang, Jie; Hao, Zhiyong; Li, Wenjing; Cui, Lianxian; He, Wei.

In: Cancer Letters, Vol. 263, No. 1, 08.05.2008, p. 99-106.

Research output: Contribution to journalArticle

Tang, Bixia ; Yang, Zhi ; Huang, Jie ; Hao, Zhiyong ; Li, Wenjing ; Cui, Lianxian ; He, Wei. / Evaluation of human major histocompatibility complex class I chain-related A as a potential target for tumor imaging. In: Cancer Letters. 2008 ; Vol. 263, No. 1. pp. 99-106.
@article{1fa127f09e224882a953e00fe12086d8,
title = "Evaluation of human major histocompatibility complex class I chain-related A as a potential target for tumor imaging",
abstract = "To investigate the feasibility of using human major histocompatibility complex class I chain-related A (MICA) as a target for tumor imaging diagnosis, 10C6, a monoclonal antibody (mAb) that specifically recognizes MICA in vitro, was labeled with 99mTc (technetium) and administered into mice bearing MICA-positive human ovarian epithelial carcinoma line SKOV3. Measurement of organ-specific radioactivity showed that tumor accumulated radioactivity continuously, while the uptake in the other organs decreased over time. Scintigram showed that the tumor became clearly visible at 24 h post-injection of radio-labeled 10C6 mAb. These results suggest that MICA is a promising target for tumor imaging and mAb 10C6 may be used clinically for early tumor diagnosis.",
keywords = "Antibody, Diagnosis, Imaging, MICA, Ovarian epithelial carcinoma, Technetium",
author = "Bixia Tang and Zhi Yang and Jie Huang and Zhiyong Hao and Wenjing Li and Lianxian Cui and Wei He",
year = "2008",
month = "5",
day = "8",
doi = "10.1016/j.canlet.2007.12.027",
language = "English",
volume = "263",
pages = "99--106",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Evaluation of human major histocompatibility complex class I chain-related A as a potential target for tumor imaging

AU - Tang, Bixia

AU - Yang, Zhi

AU - Huang, Jie

AU - Hao, Zhiyong

AU - Li, Wenjing

AU - Cui, Lianxian

AU - He, Wei

PY - 2008/5/8

Y1 - 2008/5/8

N2 - To investigate the feasibility of using human major histocompatibility complex class I chain-related A (MICA) as a target for tumor imaging diagnosis, 10C6, a monoclonal antibody (mAb) that specifically recognizes MICA in vitro, was labeled with 99mTc (technetium) and administered into mice bearing MICA-positive human ovarian epithelial carcinoma line SKOV3. Measurement of organ-specific radioactivity showed that tumor accumulated radioactivity continuously, while the uptake in the other organs decreased over time. Scintigram showed that the tumor became clearly visible at 24 h post-injection of radio-labeled 10C6 mAb. These results suggest that MICA is a promising target for tumor imaging and mAb 10C6 may be used clinically for early tumor diagnosis.

AB - To investigate the feasibility of using human major histocompatibility complex class I chain-related A (MICA) as a target for tumor imaging diagnosis, 10C6, a monoclonal antibody (mAb) that specifically recognizes MICA in vitro, was labeled with 99mTc (technetium) and administered into mice bearing MICA-positive human ovarian epithelial carcinoma line SKOV3. Measurement of organ-specific radioactivity showed that tumor accumulated radioactivity continuously, while the uptake in the other organs decreased over time. Scintigram showed that the tumor became clearly visible at 24 h post-injection of radio-labeled 10C6 mAb. These results suggest that MICA is a promising target for tumor imaging and mAb 10C6 may be used clinically for early tumor diagnosis.

KW - Antibody

KW - Diagnosis

KW - Imaging

KW - MICA

KW - Ovarian epithelial carcinoma

KW - Technetium

UR - http://www.scopus.com/inward/record.url?scp=41149131646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41149131646&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2007.12.027

DO - 10.1016/j.canlet.2007.12.027

M3 - Article

VL - 263

SP - 99

EP - 106

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -